| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,499,384,196.30 | 3,585,862,255.14 | 4,896,024,340.36 | 4,203,170,642.94 | 6,003,788,032.17 |
| Cost of Revenue
|
-3,234,916,165.23 | -3,328,961,319.20 | -4,522,338,149.23 | -3,880,250,886.32 | -5,486,630,060.13 |
|
Gross Profit
|
264,468,031.07 | 256,900,935.93 | 373,686,191.13 | 322,919,756.62 | 517,157,972.03 |
| Selling, General and Administrative Expenses
|
-113,065,612.79 | -125,997,657.95 | -137,298,147.23 | -120,667,807.89 | -106,630,814.36 |
|
Research and Development Expenses
|
-4,965,842.76 | -3,429,560.51 | -4,699,503.87 | -3,434,914.64 | -4,100,320.95 |
| Depreciation, Amortization and Depletion
|
-24,152,013.68 | -18,850,558.05 | -16,208,171.96 | -4,897,286.84 | -4,422,812.40 |
|
Operating Income/Expenses
|
-142,183,469.23 | -148,277,776.51 | -158,205,823.05 | -129,000,009.37 | -115,153,947.72 |
|
Total Operating Profit/Loss
|
122,284,561.84 | 108,623,159.42 | 215,480,368.08 | 193,919,747.26 | 402,004,024.32 |
| Total Net Finance Income/Expense
|
-13,573,177.46 | -16,952,500.74 | -34,181,987.51 | -60,929,738.58 | -80,279,633.50 |
| Net Investment Income
|
12,067,566.92 | 9,711,969.57 | -918,336.57 | 4,130,870.80 | 217,547.47 |
| Irregular Income/Expenses
|
-12,789,205.66 | 11,754,628.53 | -678,386.07 | -28,236,548.35 | -6,568,964.56 |
|
Other Income/Expense, Non-Operating
|
-93,864,279.03 | -93,276,400.19 | -92,220,976.53 | -66,051,314.92 | -65,866,881.54 |
|
Non-Operating Income/Expenses, Total
|
-108,159,095.23 | -88,762,302.84 | -127,999,686.69 | -151,086,731.05 | -152,497,932.12 |
|
Pretax Income
|
14,125,466.61 | 19,860,856.59 | 87,480,681.39 | 42,833,016.21 | 249,506,092.20 |
|
Provision for Income Tax
|
-9,176,378.79 | -15,738,465.46 | -23,281,176.38 | -23,016,251.24 | -78,446,045.10 |
|
Net Income from Continuing Operations
|
4,949,087.82 | 4,122,391.13 | 64,199,505 | 19,816,764.97 | 171,060,047.10 |
|
Other Net of Taxes Adjustments
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,949,087.82 | 4,122,391.13 | 64,199,505 | 19,816,764.97 | 171,060,047.10 |
|
Non-Controlling/Minority Interests
|
35,467,892.98 | 35,897,110.57 | 804,776.96 | 14,309,677.49 | -8,143,986.34 |
|
Net Income after Non-Controlling/Minority Interests
|
40,416,980.80 | 40,019,501.70 | 65,004,281.96 | 34,126,442.46 | 162,916,060.76 |
|
Net Income Available to Common Stockholders
|
40,416,980.80 | 40,019,501.70 | 65,004,281.96 | 34,126,442.46 | 162,916,060.76 |
|
Diluted Net Income Available to Common Stockholders
|
40,416,980.80 | 40,019,501.70 | 65,004,281.96 | 34,126,442.46 | 162,916,060.76 |
|
Common Dividend per Share
|
-- | -- | -- | 0.79 | 1.90 |
| Basic EPS
|
4.63 | 4.59 | 7.46 | 3.92 | 18.69 |
| Diluted EPS
|
4.63 | 4.59 | 7.46 | 3.92 | 18.69 |
|
Basic Weighted Average Shares Outstanding
|
8,718,845.69 | 8,718,845.69 | 8,713,710.72 | 8,715,466.60 | 8,715,466.60 |
|
Diluted Weighted Average Shares Outstanding
|
8,718,845.69 | 8,718,845.69 | 8,715,542.35 | 8,715,466.60 | 8,715,466.60 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
25,474,971.88 | 34,541,278.62 | 119,591,572.18 | 101,185,198.50 | 327,645,232.10 |
|
EBITDA
|
156,267,571.13 | 174,802,703.52 | 259,472,427.06 | 256,463,786.38 | 533,362,434.84 |
12/31/2022 - 4/8/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade